우리카지노 바카라사이트BIO organizes large-scale 우리카지노 바카라사이트n pavilion at 'BIO USA'… "Demonstrating K-bio competitiveness"

[by Yu, Suin] The 우리카지노 바카라사이트 Biotechnology Industry Organization (우리카지노 바카라사이트BIO) announced on June 10 that it has organized a large-scale 우리카지노 바카라사이트n pavilion at the 'BIO International Convention 2025 (BIO USA),' the world's largest biotechnology industry exhibition, scheduled to take place in Boston, USA, from June 16 to 19 for four days (local time). The 우리카지노 바카라사이트BIO and KOTRA will jointly operate the '우리카지노 바카라사이트 Pavilion,' covering an area of 6,000 square feet, to support the global expansion of 29 우리카지노 바카라사이트n companies and organizations.

The 우리카지노 바카라사이트 Pavilion, operated for the 22nd consecutive year, has reached its largest scale yet in terms of both the number of participating companies and the exhibition area, surpassing last year’s figures. It plans to bolster global partnering results for 우리카지노 바카라사이트n companies by strengthening customized partnering initiatives and on-site promotional activities.

The 우리카지노 바카라사이트 Pavilion exhibition will showcase companies representing the full spectrum of the biotechnology industry, including contract manufacturing (CMO) and clinical services, small and medium-sized businesses (materials, parts, and equipment), novel drug development, and platform technologies. In total, 51 companies will participate, comprising 26 companies chosen by the KoreBIO and KOTRA through a government-supported selection process and 25 companies selected by three organizations: Seoul Biohub, Chuncheon Bioindustry Foundation, and the 우리카지노 바카라사이트 Planning & Evaluation Institute of Industrial Technology (KEIT).

Notably, the partnering consultation center, which had previously operated in an open format, was partially closed to better meet the specific needs of participating companies. In addition to the exhibition promotion booth, an IR pitching stage will be set up to maximize the promotional impact of participating companies, while support for international network expansion and investment meetings will be maximized.

In addition to managing the 우리카지노 바카라사이트n Pavilion, 우리카지노 바카라사이트BIO will also participate as a representative of 우리카지노 바카라사이트 in the official meetings and conference panels at this year’s BIO USA event. On June 15 (local time), the 우리카지노 바카라사이트BIO plans to attend the closed-door general meeting of the 'International Council of Biotechnology Associations (ICBA),' where biotech association officials from around the world discuss the status of the biotechnology industry in each country and identify cooperative opportunities. At the council, 우리카지노 바카라사이트BIO aims to share major issues related to the 우리카지노 바카라사이트n biotechnology industry and highlight the importance of international cooperation. Key topics will include the domestic impact of the new U.S. government's bio-industry policies, cooperation tasks for stabilizing the global biopharmaceutical supply chain, and the current status of 우리카지노 바카라사이트’s biotech industry.

Then, on June 18, during the main event afternoon conference session titled 'Building Resilient Global and National Supply Chains,' Hwang Ju-ri, Head of Exchange and Cooperation Headquarters at the 우리카지노 바카라사이트BIO, will participate as a representative panelist for 우리카지노 바카라사이트. She will discuss strategies and international cooperation efforts aimed at securing stable supply chains in each country that have become increasingly vulnerable due to recent geopolitical tensions and climate change.

The 우리카지노 바카라사이트BIO will also organize a side event representing 우리카지노 바카라사이트. The event, '우리카지노 바카라사이트 BioTech Partnership (KBTP) @ BIO 2025,' will take place from 6 p.m. on June 17, the second day of the convention. It will be co-hosted by the 우리카지노 바카라사이트BIO, KOTRA, the 우리카지노 바카라사이트 Planning & Evaluation Institute of Industrial Technology (KEIT), the 우리카지노 바카라사이트 Exchange, Invest Seoul, and Gyeonggido Business & Science Accelerator (GBSA). The event will serve as a networking event that provides the opportunity to foster cooperation with international investors and companies.

The KBTP event is structured into two parts: Part 1 (우리카지노 바카라사이트 Capital Market Spotlight) and Part 2 (Meet the 우리카지노 바카라사이트n Biotechs). In Part 1, speakers will present 우리카지노 바카라사이트’s strategies for attracting international companies, guidelines for listing on KOSDAQ, and procedures for entering the 우리카지노 바카라사이트n market to overseas biotech firms and investors. The session will feature speakers from Invest Seoul, the 우리카지노 바카라사이트 Exchange, 우리카지노 바카라사이트 Investment Partners, Samsung Securities, Bae, Kim & Lee Law Firm, and Samil PwC Accountings, who will share practical entry strategies and insights into 우리카지노 바카라사이트’s investment and listing environment.

During the networking session of Part 2, ABL Bio, which has signed technology transfer agreements with global pharmaceutical companies like Sanofi and GlaxoSmithKline (GSK), will deliver the first presentation. Following this, Yuhan Corporation, which secured a technology transfer deal worth around KRW 1.6 trillion (approximately USD 1.1 billion) with a Johnson & Johnson (J&J) subsidiary and has received novel drug approval from the U.S. Food and Drug Administration (FDA), will participate as a speaker to share its know-how on global cooperation. The presentation will highlight strategies for 우리카지노 바카라사이트n biotech companies entering the global market and key partnership examples. In particular, the Head of Asia Partnering at Roche, a multinational pharmaceutical company, will also speak, discussing cases of collaboration with Asian and 우리카지노 바카라사이트n biotech companies and emphasizing the global potential and competitiveness of 우리카지노 바카라사이트’s bio industry.

This year’s KBTP event will bring together not only promising biotech companies but also government officials, representatives from global pharmaceutical companies, venture capitalists (VCs), and other key players who shape the global bio ecosystem, fostering extensive networking opportunities. Pre-registration for the event is available through the 우리카지노 바카라사이트BIO’s official website.

“This year, through BIO USA, we will fully support domestic biotech companies by mobilizing every available resource to promote their technologies and facilitate collaboration and exchange with international markets,” stated Hwang Ju-ri, Head of Exchange and Cooperation Headquarters at the 우리카지노 바카라사이트BIO. “We will definitely demonstrate the competitive strength of the 우리카지노 바카라사이트n bio industry in the global arena,” she added.